NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Novo Ventures’

16 April 2014

Biopharma developer PanOptica scores $45m Series B investment

Biopharmaceutical company PanOptica has raised up to $45m in a Series B financing, co-led by new participant Novo Ventures and existing investor Third Rock Ventures, alongside founding investor SV Life Sciences.

9 April 2014

Mystery investor joins venture backers in $41m Alios BioPharma Series B

virus2_sq A string of venture capital firms have renewed their backing of biotech business Alios BioPharma to help it develop treatments for respiratory viral diseases.

25 February 2014

Novo Ventures leads $49m Series B for anti-acne business Thesan Pharmaceuticals

skin5_lrg Biotechnology business Thesan Pharmaceuticals, which aims to treat skin disorders including acne and dermatitis, has picked up $49m of Series B financing led by existing backer Novo Ventures.

7 March 2013

VC firm Novo leads $48m round for Nevro Corp

news_biotech_lrg Venture capital firm Novo Ventures has thrown its support behind Nevro Corp by leading its sizeable $48m Series C funding round, which was also supported by peers Enterprise Associates and Covidien Ventures.

17 December 2012

Novo Ventures leads $32m financing for biotech company Allakos

virus2_sq Denmark-based Novo Ventures has led a $32m Series A preferred stock financing round for antibody-focused biotechnology company Allakos.

31 October 2012

Novo, Novartis lead $16m Series A for Thesan Pharmaceuticals

Thesan Pharmaceuticals has closed a $16m Series A round, co-led by corporate investment group Novo Ventures and life sciences-focused Novartis Venture Funds.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014